Status:

RECRUITING

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

Lead Sponsor:

Columbia University

Conditions:

Thyroid Nodules

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in wh...

Detailed Description

Benign multinodular goiter (MNG) refers to an enlarged thyroid gland with nodules within it, frequently owing to iodine deficiency. It is the most common endocrine disorder worldwide. Significant gro...

Eligibility Criteria

Inclusion

  • Adult patients \>/=18 years old with benign thyroid nodules

Exclusion

  • cardiac arrhythmia
  • pregnancy

Key Trial Info

Start Date :

August 30 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2027

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05189314

Start Date

August 30 2019

End Date

August 1 2027

Last Update

May 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Columbia University

New York, New York, United States, 10032

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study | DecenTrialz